A detailed history of Dmg Group, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Dmg Group, LLC holds 5,882 shares of DXCM stock, worth $445,973. This represents 0.33% of its overall portfolio holdings.

Number of Shares
5,882
Previous 4,390 33.99%
Holding current value
$445,973
Previous $497,000 20.72%
% of portfolio
0.33%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$64.0 - $116.06 $95,488 - $173,161
1,492 Added 33.99%
5,882 $394,000
Q2 2024

Jul 16, 2024

BUY
$110.31 - $140.45 $46,881 - $59,691
425 Added 10.72%
4,390 $497,000
Q1 2024

Apr 19, 2024

BUY
$114.22 - $140.1 $48,657 - $59,682
426 Added 12.04%
3,965 $549,000
Q4 2023

Jan 10, 2024

BUY
$75.49 - $124.16 $267,159 - $439,402
3,539 New
3,539 $439,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Dmg Group, LLC Portfolio

Follow Dmg Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.